Fernando Salles, Ph.D.

Chief Business Officer

Fernando Sall├ęs most recently was senior vice president and head of US and EU Business Development at I-Mab Biopharma, a China-based global biotech. Previously, he served as vice president of Global Search and Evaluation for branded products at Teva Pharmaceuticals and as executive director, Strategic Licensing and Acquisitions for ophthalmology, neuroscience, and drug delivery technologies at Merck & Co., Inc. Prior to those roles, Fernando held senior business development positions at other biopharma companies including Schering-Plough and Organon, following nine years in academic and not-for-profit research. A Certified Licensing Professional (CLP), Fernando earned his PhD in Molecular and Cellular Pharmacology at Stony Brook University, where he continues to serve as an adjunct faculty member.